Research facility · founded 1898
Roswell Park Comprehensive Cancer Center
Buffalo, United States · roswellpark.org
- Citations, last 5 years
- 77.5k
- Works, last 5 years
- 6 260
- h-index
- 729
- Scientists listed
- 671
- Grants since 2016
- 750
Grants received
2020–2025 · research · R01
Long noncoding RNA regulations in breast cancer among African-American women
Zhihong Gong · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2024 · research · R56
A novel sugar-sweetened beverage reduction intervention for Native American men
Rodney C Haring · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
RB tumor suppressor as a therapeutic target in ER-positive breast cancer
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
RB tumor suppressor as a therapeutic target in ER-positive breast cancer
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2024 · fellowship · F30
The Wnt-IRF8 axis: a Novel Regulator of Myeloid-Derived Suppressor Cell Biology
Elliot David Kramer · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2022 · research · R03
Precision vitamin D supplementation as a novel approach to prevent lung cancer progression
Pamela A Hershberger · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
Scott I. Abrams · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
Radiogenomic Credentialing of Head and Neck Cancer Models
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · research · R37
Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies
Anna Bianchi-Smiraglia · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Core B: Biostatistics and Informatics
Han Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
Walter J. Storkus · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
Pawel Kalinski · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Core D: Pathology and BioImaging
Wiam Bshara · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Core C: Clinical Management and Resources
Igor Puzanov · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Core A: Administrative Core
Pawel Kalinski · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2020–2026 · program · P01
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer
Pawel Kalinski · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2022 · research · R00
Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer
Prasenjit Dey · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2022 · research · R21
Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax
Dean G. Tang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
Dean G. Tang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2020 · research · R01
A CRISPR-based platform for testing neutrophil responses in the ovarian cancer microenvironment
Kirsten B. Moysich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Impact of novel Heat-not-Burn cigarettes on pulmonary inflammation and immunity
Maciej Lukasz Goniewicz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
Scott Andrew Gerber · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U24
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
Alan David Hutson · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2022 · fellowship · F31
Transcriptional Control of Macrophage-Mediated Mechanisms of Metastasis
Stephanie Tzetzo · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax
Dean G. Tang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC
Dean G. Tang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
Dean G. Tang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2022 · research · R00
Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer
Prasenjit Dey · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG1
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
Marc S Ernstoff · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2023 · training · T32
Multidisciplinary Approaches to Tumor Immunology
Kelvin P. Lee · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
"Combining radiation with TLR5 agonist based immunotherapy against liver metastases"
Andrei V Gudkov · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC
Dean G. Tang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2026 · research · R01
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2022 · fellowship · F31
Transcriptional Control of Macrophage-Mediated Mechanisms of Metastasis
Stephanie Tzetzo · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2026 · cooperative agreement · UG1
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
Shashikant Lele · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U24
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
Alan David Hutson · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
Edith M Lord · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
